Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Differential expression of miRNAs and related mRNAs during heat stress in buffalo heifers.

Journal of thermal biology·2021

Same author

Appropriate THI model and its threshold for goats in semi-arid regions of India.

Journal of thermal biology·2021

Same author

Dust mite induces multiple polar T cell axes in human skin.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017

Same author

Diverse models for anti-HIV activity of purine nucleoside analogs.

Chemistry Central journal·2015

Same author

Role of moving average analysis for development of multi-target (Q)SAR models.

Mini reviews in medicinal chemistry·2015

Same author

Detour matrix-based adjacent path eccentric distance sum indices for QSAR/QSPR. Part I: development and evaluation.

International journal of computational biology and drug design·2014

Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026

Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026

Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026

Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026

Same journal

Inhibitory Effects of Flavonoids from the Stems and Leaves of Scutellaria baicalensis Georgi on Oligodendrocyte Pyroptosis Induced by Aβ1-42.

Current topics in medicinal chemistry·2026

Same journal

Mechanism of Huangqishihu Decoction in Treating Liver Fibrosis in Rats Model via Regulation of Oxidative Stress and Nrf2 Signaling Pathway.

Current topics in medicinal chemistry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 14, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Classification models for anticancer activity.

R Dutt¹, A K Madan

¹Guru Gobind Singh College of Pharmacy, Yamunanagar-135001, India.

Current Topics in Medicinal Chemistry

|February 2, 2013

Summary

This summary is machine-generated.

Classification models (CMs) aid in designing selective anti-cancer drugs by predicting compound properties before synthesis. These models are crucial for developing novel anti-proliferative agents for cancer chemotherapy.

More Related Videos

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Published on: June 6, 2015

Related Experiment Videos

Last Updated: May 14, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Published on: June 6, 2015

Area of Science:

Medicinal Chemistry
Computational Chemistry
Oncology

Background:

Oncology drug development faces low success rates due to a lack of cancer cell selectivity.
Designing new chemical entities with high selectivity is crucial to minimize side effects.
Classification models (CMs) are valuable tools for predicting biological properties of potential therapeutic agents.

Purpose of the Study:

To review techniques for developing CMs for anti-cancer activity.
To illustrate the application of CMs in developing anti-proliferative activity models.
To highlight the role of CMs in identifying lead structures for novel anti-cancer agents.

Main Methods:

Review of various classification modeling techniques for anti-cancer activity.
Application of selected classification techniques to a dataset of 53 N-Benzoylated phenoxazine and phenothiazine analogues.
Development and evaluation of predictive models for anti-proliferative activity.

Main Results:

Demonstrated successful use of classification techniques for anti-proliferative activity modeling.
Generated classification models with a high degree of accuracy.
Identified potential lead structures for novel anti-proliferative agents.

Conclusions:

Classification models are significant in the development of anti-cancer agents.
Accurate CMs can guide the design of novel anti-proliferative compounds.
CMs play a vital role in advancing cancer chemotherapy drug discovery.